Home › Funds › Jupiter Research Capital (Asia) Ltd › CORT
Jupiter Research Capital (Asia) Ltd position in CORT
CORCEPT THERAPEUTICS · Health Care
Jupiter Research Capital (Asia) Ltd reported holding 72,402 shares of CORT (CORCEPT THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 0.92% of its reported portfolio and ranking #21 among its reported holdings. Jupiter Research Capital (Asia) Ltd has disclosed CORT holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
How Jupiter Research Capital (Asia) Ltd's CORT position evolved
Jupiter Research Capital (Asia) Ltd first disclosed a stake in CORT in Q1 2026 at 11,954 shares (US$482K). The position peaked in Q3 2026 at 72,402 shares, worth US$8.3M. Across 2 filings, Jupiter Research Capital (Asia) Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 72,402 shares valued at US$8.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 11.95K | $481.87K | New |
| Q3 2026 | 72.40K | $8.34M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS) is a Health Care company. 41 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$558.9M), Parallel Advisors, LLC (US$449.7M), D. E. Shaw & Co., Inc. (US$221.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 4.85M sh · $558.88M · Q3 2026
- Parallel Advisors, LLC 3.90M sh · $449.69M · Q3 2026
- D. E. Shaw & Co., Inc. 1.92M sh · $221.73M · Q3 2026
- D. E. Shaw & Co 1.92M sh · $221.73M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $172.84M · Q3 2026
- EMERALD ADVISERS, LLC 758.26K sh · $87.37M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 473.88K sh · $54.61M · Q3 2026
- MPM BioImpact LLC 422.00K sh · $48.63M · Q3 2026
- Boxer Capital Management, LLC 335.50K sh · $38.66M · Q3 2026
- FAS Wealth Partners, Inc. 317.95K sh · $36.64M · Q3 2026
More on Jupiter Research Capital (Asia) Ltd
FAQ
How long has Jupiter Research Capital (Asia) Ltd held CORT?
Jupiter Research Capital (Asia) Ltd has disclosed CORT holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Jupiter Research Capital (Asia) Ltd's current position in CORT?
As of Q3 2026, Jupiter Research Capital (Asia) Ltd holds 72.40K shares of CORT (CORCEPT THERAPEUTICS), valued at $8.34M, representing 0.92% of its reported portfolio and ranking #21.
Has Jupiter Research Capital (Asia) Ltd been buying or selling CORT?
In the latest 13F filing (Q3 2026), Jupiter Research Capital (Asia) Ltd newly opened its position in CORT. The position peaked in Q3 2026 at 72.40K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, D. E. Shaw & Co., Inc., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.